Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Sept 2026 for Royalty Pharma plc, €5.1M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
SCH Investment Partners LLC: trading record in brief
SCH Investment Partners LLC discloses dealings in Royalty Pharma plc to SEC (Form 4). Over a trading history stretching from 23 June 2026 to 22 September 2026, the count stands at 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 22 September 2026, reports a transaction of €5.1M in Royalty Pharma plc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to SCH Investment Partners LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
100,000 shares@ US$58.4697Class A Ordinary SharesSEC144:0001628280-26-063061
100,000 shares@ US$60.120.018% mcap29.9% of flowClass A Ordinary SharesSEC144:0001628280-26-057721
100,000 shares@ US$57.090.017% mcap100.0% of flowClass A Ordinary SharesSEC144:0001628280-26-046352
150,000 shares@ US$54.44510.025% mcap58.9% of flowClass A Ordinary SharesSEC144:0001628280-26-044947
4 of 4 declarations
